Maggie Flanagan LeFlore

Nessuna posizione attualmente

Consumer Services

Health Technology

Finance

Profilo

Maggie Flanagan LeFlore worked as a Managing Director at MedImmune Ventures, Inc. from 2007 to 2010.
She also worked as a Director at Astria Therapeutics, Inc. and NKT Therapeutics, Inc. In terms of education, she earned a doctorate degree from Indiana University and an undergraduate degree from the University of Kansas.

Precedenti posizioni note di Maggie Flanagan LeFlore

Società	Posizione	Fine
MedImmune Ventures, Inc. MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.	Investitore di Private Equity	30/03/2010
ASTRIA THERAPEUTICS, INC.	Direttore/Membro del Consiglio	-
NKT Therapeutics, Inc. NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA.	Direttore/Membro del Consiglio	-

Vedi nel dettaglio l'esperienza di Maggie Flanagan LeFlore

Formazione di Maggie Flanagan LeFlore

University of Kansas	Undergraduate Degree
Indiana University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Maggie Flanagan LeFlore

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
ASTRIA THERAPEUTICS, INC.	Health Technology

Aziende private	2
MedImmune Ventures, Inc. MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.	Finance
NKT Therapeutics, Inc. NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA.	Health Technology

Vedi le connessioni aziendali